# A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain

> **NCT01563614** · PHASE1 · TERMINATED · sponsor: **University Hospital, Bonn** · enrollment: 1 (actual)

## Conditions studied

- Leptomeningeal Metastasis From Malignant Melanoma

## Interventions

- **RADIATION:** Brain radiotherapy (WBRT alone, SRT/SRS alone or WBRT plus SRT/SRS)
- **DRUG:** Lomustine
- **DRUG:** Liposomal cytarabine

## Key facts

- **NCT ID:** NCT01563614
- **Lead sponsor:** University Hospital, Bonn
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.
- **Last updated:** 2016-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563614, "A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01563614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*